IDH1 and glioma: IDH1 mutation status is an important molecular marker that has been used by the World Health Organization Classification of Tumors of the Central Nervous System to define GBM as IDH1-wildtype, and IDH-mutant gliomas are characterized as astrocytoma or oligodendroglioma [29].